Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Westminster Kingsway College Launches New Access To Higher Education Programme In Pharmacy And Biomedical Sciences
Westminster Kingsway College has launched a new Access to Higher Education programme in Pharmacy and Biomedical Sciences at its new King"s Cross Centre in central London. The College is already a leading provider of Access to Higher Education courses in London as well as specialising in courses for Pharmacy Technicians in conjunction with the University of London"s School of Pharmacy and Birkbeck College.
generic viagra online
Arena Pharmaceuticals Announces The Presentation Of Lorcaserin Phase 3 BLOOM Data At The American Diabetes Association's 69th Scientific Sessions
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that a late-breaking abstract of its lorcaserin Phase 3 BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association"s 69th Scientific Sessions in New Orleans, Louisiana. The abstract, titled "Lorcaserin Reduces Body Weight in Obese and Overweight Subjects: Behavioral Modification and Lorcaserin for Overweight and Obesity Management, the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. Central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in category 20-B Obesity - Clinical Treatment.
News of the day
Offshore Industry Making Good Progress On Safety, But Sustained Effort Required, UK
18 months on from the landmark KP3 report, a "snapshot" review concludes that though the safety of the UK"s offshore installations is improving, the work is by no means complete and will require sustained effort and investment.
Public Health

Aspirin As A Prophylaxis For Fatal Pulmonary Embolism

A study published provides results which challenge the current NICE guidelines (set in April 2007) relating to the use of low-molecular weight heparin (LMWH) rather than aspirin as a thromboprophylaxis following orthopaedic surgery. Currently the guidance states that LMWH is preferable to aspirin and partly is based on two assumptions that the report"s authors wished to test: that chemical and/or mechanical prophylaxis will reduce these complications and that orthopaedic operations, in particular elective hip and knee replacements, are high-risk. The study analysed over 4,000 patients undergoing primary joint replacement, the majority of whom received aspirin only as a chemical prophylaxis. The overall death rate was 0.31% and the rate of fatal pulmonary embolism was 0.07%, while the overall mortality rate in the general population for gender and age matched controls was 50% more than those undergoing surgery. Therefore, the report"s authors conclude that "it does seem unlikely that the adoption of LMWH could produce any further significant reduction on observed mortality in this patient group". In addition, "the fatal pulmonary embolism rate (0.07%) suggests that this is a rare event even after elective total joint replacement if aspirin is given", meaning that aspirin is an effective thromprophylaxis for patients after orthopaedic surgery. Read the full text article. The Journal of Bone and Joint Surgery


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009